VCELVericel Corp

Nasdaq vcel.com


$ 45.87 $ 1.60 (3.61 %)    

Friday, 13-Sep-2024 15:59:55 EDT
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 45.87
$ 45.01
$ 45.84 x 179
-- x --
$ 44.92 - $ 46.64
$ 30.18 - $ 54.10
329,586
na
2.25B
$ 1.63
$ 2,850.46
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-05-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-13-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-14-2016 12-31-2015 10-K
36 11-13-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-25-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-vericel-raises-price-target-to-60

TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $60.

 vericel-gains-fda-approval-for-arthroscopic-delivery-of-maci-in-knee-cartilage-treatments

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today a...

 vericel-corp-files-for-mixed-shelf-offering-size-not-disclosed

- SEC Filing

 vericel-gets-fda-approval-of-nexobrid-for-the-treatment-of-pediatric-patients-with-severe-thermal-burns

Approval Expands NexoBrid Target Customer Base to Include Approximately 20 Pediatric Burn CentersCAMBRIDGE, Mass., Aug. 15, 202...

 expert-ratings-for-vericel
Expert Ratings For Vericel
08/09/2024 14:00:56

 canaccord-genuity-initiates-coverage-on-vericel-with-buy-rating-announces-price-target-of-57

Canaccord Genuity analyst Caitlin Cronin initiates coverage on Vericel (NASDAQ:VCEL) with a Buy rating and announces Price T...

 stephens--co-maintains-overweight-on-vericel-raises-price-target-to-58

Stephens & Co. analyst George Sellers maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-60

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-affirms-fy24-sales-guidance-of-238m-242m-vs-24027m-estimate

2024 Financial Guidance   Reaffirmed total net revenue guidance of $238 to $242 million, or 20% to 23% growth Profitabilit...

 vericel-q2-2024-gaap-eps-010-misses-009-estimate-sales-52662m-beat-52586m-estimate

Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by ...

 truist-securities-maintains-buy-on-vericel-raises-price-target-to-57

Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $56 t...

 btig-maintains-buy-on-vericel-lowers-price-target-to-55

BTIG analyst Ryan Zimmerman maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $56 to $55.

 td-cowen-initiates-coverage-on-vericel-with-buy-rating-announces-price-target-of-55

TD Cowen analyst Joshua Jennings initiates coverage on Vericel (NASDAQ:VCEL) with a Buy rating and announces Price Target of...

 hc-wainwright--co-maintains-buy-on-vericel-raises-price-target-to-55

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price targe...

 vericel-raises-fy24-revenue-guidance-from-237m-241m-to-238m-242m-vs-23924m-est

2024 Financial GuidanceTotal net revenue for 2024 now expected to be in the range of $238 to $242 million, compared to the prev...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION